|
GS185131: GO:0044699 single-organism process
|
|
GS207306: GO:0080134 regulation of response to stress
|
|
GS197164: GO:0046328 regulation of JNK cascade
|
|
GS170247: MP:0002038 carcinoma
|
|
GS200100: GO:0035022 positive regulation of Rac protein signal transduction
|
|
GS190171: GO:0051057 positive regulation of small GTPase mediated signal transduction
|
|
GS205510: GO:0001883 purine nucleoside binding
|
|
GS198861: GO:0007167 enzyme linked receptor protein signaling pathway
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS136784: seizure severity 2 (Szv2, Published QTL Chr 7)
|
|
GS204803: GO:0071779 G1/S transition checkpoint
|
|
GS199701: GO:0003924 GTPase activity
|
|
GS175695: HP:0006766 Papillary renal cell carcinoma
|
|
GS166949: MP:0009308 adenocarcinoma
|
|
GS136339: nicotine induced locomotor activity 4 (Nilac4, Published QTL Chr 7)
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS184984: GO:0032553 ribonucleotide binding
|
|
GS123377: Glucose interacting genes (MeSH:D005947) in CTD
|
|
GS182241: GO:0043068 positive regulation of programmed cell death
|
|
GS176151: HP:0000256 Macrocephaly
|
|
GS195083: GO:0007267 cell-cell signaling
|
|
GS176255: HP:0002780 Bronchomalacia
|
|
GS201231: GO:0060548 negative regulation of cell death
|
|
GS176385: HP:0001249 Intellectual disability
|
|
GS172701: HP:0002650 Scoliosis
|
|
GS170969: HP:0000157 Abnormality of the tongue
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS165992: MP:0008469 abnormal protein level
|
|
GS207290: GO:0032874 positive regulation of stress-activated MAPK cascade
|
|
GS175332: HP:0000032 Abnormality of male external genitalia
|
|
GS179950: GO:0006259 DNA metabolic process
|
|
GS172843: HP:0000481 Abnormality of the cornea
|
|
GS178334: GO:0007267 cell-cell signaling
|
|
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
|
|
GS206108: GO:2001141 regulation of RNA biosynthetic process
|
|
GS171718: HP:0002808 Kyphosis
|
|
GS171286: HP:0002996 Limited elbow movement
|
|
GS196343: GO:0036094 small molecule binding
|
|
GS184324: GO:0010646 regulation of cell communication
|
|
GS173385: HP:0002751 Kyphoscoliosis
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS210137: GO:0016462 pyrophosphatase activity
|
|
GS207925: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS172060: HP:0001508 Failure to thrive
|
|
GS201159: GO:2000045 regulation of G1/S transition of mitotic cell cycle
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS165080: MP:0001883 mammary adenocarcinoma
|
|
GS170024: MP:0011086 partial postnatal lethality
|
|
GS164333: MP:0000516 abnormal renal/urinary system morphology
|
|
GS126466: Quercetin interacting genes (MeSH:D011794) in CTD
|
|
GS172570: HP:0000341 Narrow forehead
|
|
GS183543: GO:0051179 localization
|
|
GS121375: doxifluridine interacting genes (MeSH:C025034) in CTD
|
|
GS162953: MP:0002020 increased tumor incidence
|
|
GS175907: HP:0004349 Reduced bone mineral density
|
|
GS205500: GO:0071944 cell periphery
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS209108: GO:0000166 nucleotide binding
|
|
GS124618: Heptachlor interacting genes (MeSH:D006533) in CTD
|
|
GS208675: GO:0022403 cell cycle phase
|
|
GS181721: GO:0006163 purine nucleotide metabolic process
|
|
GS176615: HP:0000277 Abnormality of the mandible
|
|
GS176789: HP:0100872 Abnormality of the plantar skin of foot
|
|
GS172765: HP:0001680 Coarctation of aorta
|
|
GS173511: HP:0000307 Pointed chin
|
|
GS207285: GO:0032872 regulation of stress-activated MAPK cascade
|
|
GS127931: Olfactory bulb - Allen Mouse Brain Atlas
|
|
GS198240: GO:0031399 regulation of protein modification process
|
|
GS176589: HP:0001273 Abnormality of the corpus callosum
|
|
GS167615: MP:0003935 abnormal craniofacial development
|
|
GS193937: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS206237: GO:0042981 regulation of apoptotic process
|
|
GS189072: GO:0043408 regulation of MAPK cascade
|
|
GS173449: HP:0002683 Abnormality of the calvaria
|
|
GS164042: MP:0002018 malignant tumors
|
|
GS166409: MP:0002114 abnormal axial skeleton morphology
|
|
GS201696: GO:0010941 regulation of cell death
|
|
GS201367: GO:0019538 protein metabolic process
|
|
GS174194: HP:0009728 Neoplasm of striated muscle
|
|
GS182982: GO:0043066 negative regulation of apoptotic process
|
|
GS175171: HP:0001315 Reduced tendon reflexes
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS195340: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS178401: GO:0019637 organophosphate metabolic process
|
|
GS186744: GO:0043226 organelle
|
|
GS182835: GO:0005622 intracellular
|
|
GS205439: GO:0031175 neuron projection development
|
|
GS84199: METH responses for body temperature (Published QTL, Chr 7)
|
|
GS201756: GO:0042692 muscle cell differentiation
|
|
GS202468: GO:0070887 cellular response to chemical stimulus
|
|
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS195541: GO:0000278 mitotic cell cycle
|
|
GS203482: GO:0044093 positive regulation of molecular function
|
|
GS176375: HP:0000269 Prominent occiput
|
|
GS164668: MP:0010293 increased integument system tumor incidence
|
|
GS165921: MP:0000091 short premaxilla
|
|
GS205302: GO:0000139 Golgi membrane
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS180225: GO:0051403 stress-activated MAPK cascade
|
|
GS127934: Retrohippocampal region - Allen Mouse Brain Atlas
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS165877: MP:0002136 abnormal kidney physiology
|
|
GS171645: HP:0011843 Abnormality of skeletal physiology
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS204150: GO:0009611 response to wounding
|
|
GS196633: GO:0070997 neuron death
|
|
GS168939: MP:0000120 malocclusion
|
|
GS182081: GO:0031575 mitotic cell cycle G1/S transition checkpoint
|
|
GS175896: HP:0000938 Osteopenia
|
|
GS186301: GO:0031401 positive regulation of protein modification process
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS180190: GO:0051329 interphase of mitotic cell cycle
|
|
GS200341: GO:0051179 localization
|
|
GS206742: GO:0043167 ion binding
|
|
GS167907: MP:0003921 abnormal heart left ventricle morphology
|
|
GS174994: HP:0002059 Cerebral atrophy
|
|
GS175428: HP:0009591 Abnormality of the vestibulocochlear nerve
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS163052: MP:0000266 abnormal heart morphology
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS172906: HP:0003319 Abnormality of the cervical spine
|
|
GS174605: HP:0001609 Hoarse voice
|
|
GS126316: Acetylcysteine interacting genes (MeSH:D000111) in CTD
|
|
GS165208: MP:0002842 increased systemic arterial blood pressure
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS175823: HP:0002093 Respiratory insufficiency
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS124118: vinyl carbamate interacting genes (MeSH:C017963) in CTD
|
|
GS195710: GO:0032268 regulation of cellular protein metabolic process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS177859: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS195594: GO:0010562 positive regulation of phosphorus metabolic process
|
|
GS180644: GO:0032549 ribonucleoside binding
|
|
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
|
|
GS173288: HP:0000316 Hypertelorism
|
|
GS182665: GO:0042278 purine nucleoside metabolic process
|
|
GS198004: GO:0007399 nervous system development
|
|
GS126756: tobacco tar interacting genes (MeSH:C024746) in CTD
|
|
GS169389: MP:0002060 abnormal skin morphology
|
|
GS164264: MP:0002082 postnatal lethality
|
|
GS203058: GO:0048519 negative regulation of biological process
|
|
GS196968: GO:0051329 interphase of mitotic cell cycle
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS198017: GO:0044344 cellular response to fibroblast growth factor stimulus
|
|
GS173835: HP:0003422 Vertebral segmentation defect
|
|
GS172374: HP:0002862 Bladder carcinoma
|
|
GS35276: Striatum Gene expression correlates of Maximum startle response to 85 db in Males BXD
|
|
GS163083: MP:0010279 increased gastrointestinal tumor incidence
|
|
GS176571: HP:0008067 Abnormally lax or hyperextensible skin
|
|
GS209284: GO:0010627 regulation of intracellular protein kinase cascade
|
|
GS176094: HP:0100008 Schwannoma
|
|
GS124506: bicyclol interacting genes (MeSH:C477843) in CTD
|
|
GS136732: susceptibility to lung cancer 8 (Sluc8, Published QTL Chr 7)
|
|
GS171179: HP:0003764 Nevus
|
|
GS175529: HP:0000001 All
|
|
GS173071: HP:0001816 Thin nail
|
|
GS190174: GO:0051054 positive regulation of DNA metabolic process
|
|
GS188962: GO:1901292 nucleoside phosphate catabolic process
|
|
GS175527: HP:0000006 Autosomal dominant inheritance
|
|
GS178589: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS183592: GO:0032561 guanyl ribonucleotide binding
|
|
GS199986: GO:0009719 response to endogenous stimulus
|
|
GS173872: HP:0011368 Epidermal thickening
|
|
GS173806: HP:0002816 Genu recurvatum
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS170182: MP:0001473 reduced long term potentiation
|
|
GS173959: HP:0001582 Redundant skin
|
|
GS191700: GO:0006753 nucleoside phosphate metabolic process
|
|
GS172288: HP:0000358 Posteriorly rotated ears
|
|
GS199739: GO:0046578 regulation of Ras protein signal transduction
|
|
GS121385: epicatechin gallate interacting genes (MeSH:C062669) in CTD
|
|
GS174926: HP:0000768 Pectus carinatum
|
|
GS181450: GO:0031399 regulation of protein modification process
|
|
GS187420: GO:0031644 regulation of neurological system process
|
|
GS174451: HP:0006705 Abnormality of the atrioventricular valves
|
|
GS188506: GO:0010467 gene expression
|
|
GS208012: GO:0044464 cell part
|
|
GS192405: GO:0070372 regulation of ERK1 and ERK2 cascade
|
|
GS186430: GO:0007243 intracellular protein kinase cascade
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS167751: MP:0000628 abnormal mammary gland development
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS200867: GO:0043085 positive regulation of catalytic activity
|
|
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS195940: GO:0007010 cytoskeleton organization
|
|
GS194101: GO:0050817 coagulation
|
|
GS207067: GO:0051054 positive regulation of DNA metabolic process
|
|
GS169428: MP:0010429 abnormal heart left ventricle outflow tract morphology
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS195607: GO:0070302 regulation of stress-activated protein kinase signaling cascade
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS124969: theaflavin interacting genes (MeSH:C056068) in CTD
|
|
GS202556: GO:0043434 response to peptide hormone stimulus
|
|
GS185016: GO:0097193 intrinsic apoptotic signaling pathway
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS176771: HP:0001000 Abnormality of skin pigmentation
|
|
GS187943: GO:0071779 G1/S transition checkpoint
|
|
GS190492: GO:0009154 purine ribonucleotide catabolic process
|
|
GS192725: GO:0046330 positive regulation of JNK cascade
|
|
GS203755: GO:0016265 death
|
|
GS185236: GO:0006184 GTP catabolic process
|
|
GS177051: HP:0001155 Abnormality of the hand
|
|
GS191317: GO:0006897 endocytosis
|
|
GS199591: GO:0042060 wound healing
|
|
GS126206: Nicotine interacting genes (MeSH:D009538) in CTD
|
|
GS178855: GO:0070304 positive regulation of stress-activated protein kinase signaling cascade
|
|
GS199635: GO:0005622 intracellular
|
|
GS193527: GO:1901068 guanosine-containing compound metabolic process
|
|
GS172037: HP:0001187 Hyperextensibility of the finger joints
|
|
GS121437: Fluorouracil interacting genes (MeSH:D005472) in CTD
|
|
GS165244: MP:0010771 integument phenotype
|
|
GS196941: GO:0008150 biological_process
|
|
GS176289: HP:0002120 Cerebral cortical atrophy
|
|
GS124695: arsenic trioxide interacting genes (MeSH:C006632) in CTD
|
|
GS188290: GO:0009966 regulation of signal transduction
|
|
GS174198: HP:0009720 Adenoma sebaceum
|
|
GS176449: HP:0001671 Abnormality of the cardiac septa
|
|
GS175539: HP:0007256 Abnormality of pyramidal motor function
|
|
GS201256: GO:0044422 organelle part
|
|
GS200030: GO:0032868 response to insulin stimulus
|
|
GS170158: MP:0000074 abnormal neurocranium morphology
|
|
GS176055: HP:0002132 Porencephaly
|
|
GS196282: GO:0012501 programmed cell death
|
|
GS170824: HP:0002164 Nail dysplasia
|
|
GS162896: MP:0003985 renal fibrosis
|
|
GS205472: GO:0009416 response to light stimulus
|
|
GS206192: GO:0048583 regulation of response to stimulus
|
|
GS173147: HP:0011283 Abnormality of the metencephalon
|
|
GS166790: MP:0009873 abnormal aorta tunica media morphology
|
|
GS175594: HP:0011014 Abnormal glucose homeostasis
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS171157: HP:0100742 Vascular neoplasm
|
|
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS175016: HP:0001626 Abnormality of the cardiovascular system
|
|
GS175117: HP:0001883 Talipes
|
|
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS174380: HP:0010624 Aplastic/hypoplastic toenails
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS202080: GO:0051252 regulation of RNA metabolic process
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS166907: MP:0008725 enlarged heart atrium
|
|
GS172253: HP:0001376 Limitation of joint mobility
|
|
GS190496: GO:0009150 purine ribonucleotide metabolic process
|
|
GS174606: HP:0001608 Abnormality of the voice
|
|
GS173343: HP:0001548 Overgrowth
|
|
GS188556: GO:0042325 regulation of phosphorylation
|
|
GS175015: HP:0001627 Abnormality of the heart
|
|
GS173838: HP:0002778 Abnormality of the trachea
|
|
GS175096: HP:0000286 Epicanthus
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS184629: GO:0005515 protein binding
|
|
GS172871: HP:0010490 Abnormality of the palmar creases
|
|
GS176186: HP:0000079 Abnormality of the urinary system
|
|
GS190172: GO:0051056 regulation of small GTPase mediated signal transduction
|
|
GS210236: GO:0000904 cell morphogenesis involved in differentiation
|
|
GS135273: "alcohol preference locus 14, female specific" (Alcp14, Published QTL Chr 7)
|
|
GS173993: HP:0000506 Telecanthus
|
|
GS178785: GO:0000278 mitotic cell cycle
|
|
GS167152: MP:0000455 abnormal maxilla morphology
|
|
GS188569: GO:0006275 regulation of DNA replication
|
|
GS176900: HP:0000218 High palate
|
|
GS168931: MP:0001431 abnormal eating behavior
|
|
GS179518: GO:0012502 induction of programmed cell death
|
|
GS171345: HP:0001048 Cavernous hemangioma
|
|
GS167439: MP:0000443 abnormal snout morphology
|
|
GS135720: determination of interleukin 4 commitment 2 (Dice2, Published QTL Chr 7)
|
|
GS192403: GO:0070374 positive regulation of ERK1 and ERK2 cascade
|
|
GS202961: GO:0019098 reproductive behavior
|
|
GS176500: HP:0007099 Arnold-Chiari type I malformation
|
|
GS86984: Table S2: The data provided represent genes showing differential expression using ANOVA. A. Genes showing main effect of strain. [DRG]
provisional
|
|
GS185991: GO:0016817 hydrolase activity, acting on acid anhydrides
|
|
GS188558: GO:0042327 positive regulation of phosphorylation
|
|
GS175480: HP:0006191 Deep palmar creases
|
|
GS184261: GO:0006260 DNA replication
|
|
GS206428: GO:0001932 regulation of protein phosphorylation
|
|
GS199740: GO:0046579 positive regulation of Ras protein signal transduction
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS206430: GO:0001934 positive regulation of protein phosphorylation
|
|
GS169836: MP:0005388 respiratory system phenotype
|
|
GS166718: MP:0002169 no abnormal phenotype detected
|
|
GS171171: HP:0005607 Abnormality of the tracheobronchial system
|
|
GS175602: HP:0002087 Abnormality of the upper respiratory tract
|
|
GS192461: GO:0046130 purine ribonucleoside catabolic process
|
|
GS182175: GO:0006152 purine nucleoside catabolic process
|
|
GS201075: GO:0005794 Golgi apparatus
|
|
GS184214: GO:0046039 GTP metabolic process
|
|
GS196806: GO:0032502 developmental process
|
|
GS187633: GO:0019693 ribose phosphate metabolic process
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS170044: MP:0008874 decreased physiological sensitivity to xenobiotic
|
|
GS172667: HP:0011805 Abnormality of muscle morphology
|
|
GS206715: GO:0051674 localization of cell
|
|
GS174879: HP:0002104 Apnea
|
|
GS172604: HP:0005445 Widened posterior fossa
|
|
GS194172: GO:0006915 apoptotic process
|
|
GS179822: GO:0006468 protein phosphorylation
|
|
GS193491: GO:0072523 purine-containing compound catabolic process
|
|
GS194586: GO:0002376 immune system process
|
|
GS172655: HP:0001792 Small nail
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS167442: MP:0000440 domed cranium
|
|
GS169396: MP:0002069 abnormal eating/drinking behavior
|
|
GS182705: GO:0051173 positive regulation of nitrogen compound metabolic process
|
|
GS200028: GO:0032869 cellular response to insulin stimulus
|
|
GS174647: HP:0000956 Acanthosis nigricans
|
|
GS184198: GO:0044270 cellular nitrogen compound catabolic process
|
|
GS208019: GO:0051347 positive regulation of transferase activity
|
|
GS207991: GO:0000003 reproduction
|
|
GS164742: MP:0001732 postnatal growth retardation
|
|
GS35261: Striatum Gene expression correlates of Maximum startle response to 80 db in Females BXD
|
|
GS166375: MP:0001436 abnormal suckling behavior
|
|
GS168358: MP:0000107 abnormal frontal bone morphology
|
|
GS185008: GO:0097190 apoptotic signaling pathway
|
|
GS174179: HP:0002514 Cerebral calcification
|
|
GS127924: Cerebral cortex - Allen Mouse Brain Atlas
|
|
GS136763: soft tissue heal 7 (Stheal7, Published QTL Chr 7)
|
|
GS127925: Hippocampal formation - Allen Mouse Brain Atlas
|
|
GS173465: HP:0001654 Abnormality of the heart valves
|
|
GS206111: GO:0097285 cell-type specific apoptotic process
|
|
GS168750: MP:0002191 abnormal artery morphology
|
|
GS196196: GO:0022414 reproductive process
|
|
GS174665: HP:0001428 Somatic mutation
|
|
GS175304: HP:0000290 Abnormality of the forehead
|
|
GS177356: GO:0003674 molecular_function
|
|
GS191722: GO:0008285 negative regulation of cell proliferation
|
|
GS166180: MP:0010299 increased mammary gland tumor incidence
|
|
GS180149: GO:0065003 macromolecular complex assembly
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS199032: GO:0036211 protein modification process
|
|
GS171390: HP:0000178 Abnormality of lower lip
|
|
GS177717: GO:0051239 regulation of multicellular organismal process
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS208058: GO:0007411 axon guidance
|
|
GS210537: GO:2000602 regulation of interphase of mitotic cell cycle
|
|
GS171836: HP:0011328 Abnormality of fontanelles
|
|
GS173880: HP:0005750 Contractures of the joints of the lower limbs
|
|
GS172034: HP:0000368 Low-set, posteriorly rotated ears
|
|
GS175785: HP:0002500 Abnormality of the cerebral white matter
|
|
GS209865: GO:0050890 cognition
|
|
GS186822: GO:0000075 cell cycle checkpoint
|
|
GS194647: GO:0071495 cellular response to endogenous stimulus
|
|
GS172272: HP:0001197 Abnormality of prenatal development or birth
|
|
GS188410: GO:0032774 RNA biosynthetic process
|
|
GS178850: GO:0070302 regulation of stress-activated protein kinase signaling cascade
|
|
GS191727: GO:0008283 cell proliferation
|
|
GS177048: HP:0011371 Recurrent viral skin infections
|
|
GS172883: HP:0002308 Arnold-Chiari malformation
|
|
GS206091: GO:0007610 behavior
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS184267: GO:0005794 Golgi apparatus
|
|
GS203072: GO:0090304 nucleic acid metabolic process
|
|
GS174788: HP:0000239 Large fontanelles
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS171251: HP:0003549 Abnormality of connective tissue
|
|
GS174076: HP:0009122 Aplasia/Hypoplasia affecting bones of the axial skeleton
|
|
GS127937: Striatum-like amygdalar nuclei - Allen Mouse Brain Atlas
|
|
GS122453: Chlorine interacting genes (MeSH:D002713) in CTD
|
|
GS187193: GO:0044057 regulation of system process
|
|
GS175440: HP:0009748 Large earlobe
|
|
GS176886: HP:0100261 Abnormal tendon morphology
|
|
GS174882: HP:0006762 Renal pelvic carcinoma
|
|
GS175537: HP:0011277 Abnormality of the urinary system physiology
|
|
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
|
|
GS176560: HP:0001010 Hypopigmentation of the skin
|
|
GS194065: GO:0016192 vesicle-mediated transport
|
|
GS165876: MP:0002135 abnormal kidney morphology
|
|
GS171144: HP:0005280 Depressed nasal bridge
|
|
GS136142: lithogenic gene 22 (Lith22, Published QTL Chr 7)
|
|
GS169424: MP:0005558 decreased creatinine clearance
|
|
GS126594: Nucleosides interacting genes (MeSH:D009705) in CTD
|
|
GS174289: HP:0002577 Abnormality of the stomach
|
|
GS171627: HP:0000470 Short neck
|
|
GS173787: HP:0002813 Abnormality of limb bone morphology
|
|
GS182981: GO:0043067 regulation of programmed cell death
|
|
GS186237: GO:0009143 nucleoside triphosphate catabolic process
|
|
GS195853: GO:0007093 mitotic cell cycle checkpoint
|
|
GS205758: GO:0016477 cell migration
|
|
GS193237: GO:0031325 positive regulation of cellular metabolic process
|
|
GS176171: HP:0001250 Seizures
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS195596: GO:0010564 regulation of cell cycle process
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS173081: HP:0000494 Downslanted palpebral fissures
|
|
GS201794: GO:0032555 purine ribonucleotide binding
|
|
GS194602: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS189535: GO:0010740 positive regulation of intracellular protein kinase cascade
|
|
GS171391: HP:0000179 Thick lower lip vermilion
|
|
GS171148: HP:0011218 Abnormal shape of the frontal region
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS172094: HP:0000589 Coloboma
|
|
GS174917: HP:0000765 Abnormality of the thorax
|
|
GS177000: HP:0001291 Abnormality of the cranial nerves
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS205935: GO:0043408 regulation of MAPK cascade
|
|
GS187023: GO:1901265 nucleoside phosphate binding
|
|
GS164831: MP:0010578 abnormal heart left ventricle size
|
|
GS169668: MP:0002014 increased papilloma incidence
|
|
GS172268: HP:0001193 Ulnar deviation of the hand or of fingers of the hand
|
|
GS174806: HP:0001631 Defect in the atrial septum
|
|
GS182990: GO:0043069 negative regulation of programmed cell death
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS172136: HP:0002859 Rhabdomyosarcoma
|
|
GS207069: GO:0051052 regulation of DNA metabolic process
|
|
GS193009: GO:0042127 regulation of cell proliferation
|
|
GS126346: Beryllium interacting genes (MeSH:D001608) in CTD
|
|
GS35271: Striatum Gene expression correlates of Maximum startle response to 85 db in Females BXD
|
|
GS197275: GO:0033554 cellular response to stress
|
|
GS190067: GO:0018130 heterocycle biosynthetic process
|
|
GS191870: GO:0009259 ribonucleotide metabolic process
|
|
GS203147: GO:0031401 positive regulation of protein modification process
|
|
GS198394: GO:0050679 positive regulation of epithelial cell proliferation
|
|
GS168032: MP:0009866 abnormal aorta wall morphology
|
|
GS205266: GO:0032774 RNA biosynthetic process
|
|
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
|
|
GS195977: GO:0007154 cell communication
|
|
GS174295: HP:0010786 Urinary tract neoplasm
|
|
GS135571: cystic fibrosis body weight 3 (Cfbw3, Published QTL Chr 7)
|
|
GS125728: capecitabine interacting genes (MeSH:C110904) in CTD
|
|
GS192171: GO:0000165 MAPK cascade
|
|
GS176699: HP:0002109 Abnormality of the bronchi
|
|
GS177959: GO:0051726 regulation of cell cycle
|
|
GS173287: HP:0000315 Abnormality of the orbital region
|
|
GS180120: GO:0009205 purine ribonucleoside triphosphate metabolic process
|
|
GS121822: Calcimycin interacting genes (MeSH:D000001) in CTD
|
|
GS194905: GO:0008219 cell death
|
|
GS205691: GO:0022008 neurogenesis
|
|
GS208389: GO:0048168 regulation of neuronal synaptic plasticity
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS198274: GO:0035556 intracellular signal transduction
|
|
GS124531: limonene interacting genes (MeSH:C008281) in CTD
|
|
GS172362: HP:0004325 Decreased body weight
|
|
GS175597: HP:0011013 Abnormality of carbohydrate metabolism/homeostasis
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS127939: Thalamus - Allen Mouse Brain Atlas
|
|
GS171385: HP:0001552 Barrel-shaped chest
|
|
GS165224: MP:0000627 abnormal mammary gland morphology
|
|
GS206953: GO:0018130 heterocycle biosynthetic process
|
|
GS207577: GO:0007270 neuron-neuron synaptic transmission
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS180164: GO:0008150 biological_process
|
|
GS174812: HP:0001637 Abnormality of the myocardium
|
|
GS202897: GO:0050878 regulation of body fluid levels
|
|
GS173092: HP:0004375 Neoplasm of the nervous system
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS178336: GO:0007265 Ras protein signal transduction
|
|
GS123393: benzo(a)pyrene-3,6-quinone interacting genes (MeSH:C018003) in CTD
|
|
GS164004: MP:0011101 partial prenatal lethality
|
|
GS165437: MP:0000438 abnormal cranium morphology
|
|
GS175305: HP:0000293 Full cheeks
|
|
GS174026: HP:0002033 Poor suck
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS171833: HP:0000119 Abnormality of the genitourinary system
|
|
GS167688: MP:0003108 short zygomatic bone
|
|
GS177214: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS176756: HP:0011420 Death
|
|
GS180482: GO:0033554 cellular response to stress
|
|
GS176856: HP:0005584 Renal cell carcinoma
|
|
GS176191: HP:0002870 Obstructive sleep apnea
|
|
GS207858: GO:0009059 macromolecule biosynthetic process
|
|
GS176416: HP:0100679 Lack of skin elasticity
|
|
GS209232: GO:0006796 phosphate-containing compound metabolic process
|
|
GS127933: Pons - Allen Mouse Brain Atlas
|
|
GS209343: GO:0070371 ERK1 and ERK2 cascade
|
|
GS188707: GO:0045786 negative regulation of cell cycle
|
|
GS190954: GO:0009056 catabolic process
|
|
GS197670: GO:0051247 positive regulation of protein metabolic process
|
|
GS171258: HP:0011138 Abnormality of skin adnexa
|
|
GS122305: resveratrol interacting genes (MeSH:C059514) in CTD
|
|
GS200602: GO:0044267 cellular protein metabolic process
|
|
GS174200: HP:0009726 Renal neoplasm
|
|
GS209340: GO:0070374 positive regulation of ERK1 and ERK2 cascade
|
|
GS176885: HP:0002693 Abnormality of the skull base
|
|
GS124131: ferrous sulfate interacting genes (MeSH:C020748) in CTD
|
|
GS196004: GO:0045859 regulation of protein kinase activity
|
|
GS166363: MP:0009503 abnormal mammary gland duct morphology
|
|
GS202822: GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
|
|
GS197114: GO:0043524 negative regulation of neuron apoptotic process
|
|
GS168067: MP:0002625 heart left ventricle hypertrophy
|
|
GS176836: HP:0000422 Abnormality of the nasal bridge
|
|
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS199947: GO:0007612 learning
|
|
GS180878: GO:0051246 regulation of protein metabolic process
|
|
GS122308: Nitrofurazone interacting genes (MeSH:D009583) in CTD
|
|
GS176677: HP:0100273 Neoplasm of the colon
|
|
GS204996: GO:0048858 cell projection morphogenesis
|
|
GS174646: HP:0000951 Abnormality of the skin
|
|
GS181604: GO:0050679 positive regulation of epithelial cell proliferation
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS201949: GO:0044699 single-organism process
|
|
GS176725: HP:0011425 Fetal ultrasound soft marker
|
|
GS187749: GO:0019220 regulation of phosphate metabolic process
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS170962: HP:0000159 Abnormality of the lip
|
|
GS169577: MP:0010224 abnormal heart ventricle outflow tract morphology
|
|
GS188641: GO:0071944 cell periphery
|
|
GS189244: GO:0097285 cell-type specific apoptotic process
|
|
GS209569: GO:0048667 cell morphogenesis involved in neuron differentiation
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS176464: HP:0100242 Sarcoma
|
|
GS124919: Butylated Hydroxytoluene interacting genes (MeSH:D002084) in CTD
|
|
GS175900: HP:0009118 Aplasia/Hypoplasia of the mandible
|
|
GS190176: GO:0051052 regulation of DNA metabolic process
|
|
GS181223: GO:0046434 organophosphate catabolic process
|
|
GS190950: GO:0009059 macromolecule biosynthetic process
|
|
GS181568: GO:0006357 regulation of transcription from RNA polymerase II promoter
|
|
GS126516: benzo(a)pyrene 7,8-dihydrodiol interacting genes (MeSH:C017228) in CTD
|
|
GS123883: Methylnitrosourea interacting genes (MeSH:D008770) in CTD
|
|
GS166154: MP:0011098 complete embryonic lethality during organogenesis
|
|
GS173308: HP:0001808 Fragile nails
|
|
GS178461: GO:0009987 cellular process
|
|
GS198873: GO:0031575 mitotic cell cycle G1/S transition checkpoint
|
|
GS173946: HP:0002438 Cerebellar malformation
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS166380: MP:0008872 abnormal physiological response to xenobiotic
|
|
GS167702: MP:0003141 cardiac fibrosis
|
|
GS200393: GO:0032561 guanyl ribonucleotide binding
|
|
GS176899: HP:0002353 EEG abnormality
|
|
GS204284: GO:0031644 regulation of neurological system process
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS199251: GO:0032147 activation of protein kinase activity
|
|
GS210507: GO:0006950 response to stress
|
|
GS173384: HP:0002750 Delayed skeletal maturation
|
|
GS186240: GO:0009146 purine nucleoside triphosphate catabolic process
|
|
GS175391: HP:0011004 Abnormality of the systemic arterial tree
|
|
GS174002: HP:0000189 Narrow palate
|
|
GS174612: HP:0001600 Abnormality of the larynx
|
|
GS174488: HP:0000525 Abnormality of the iris
|
|
GS169973: MP:0002006 tumorigenesis
|
|
GS167149: MP:0000452 abnormal mouth morphology
|
|
GS203276: GO:0007243 intracellular protein kinase cascade
|
|
GS173148: HP:0003712 Muscle hypertrophy
|
|
GS179830: GO:0006464 cellular protein modification process
|
|
GS167356: MP:0002207 abnormal long term potentiation
|
|
GS200956: GO:0008306 associative learning
|
|
GS121612: Adenosine Diphosphate interacting genes (MeSH:D000244) in CTD
|
|
GS181892: GO:0048523 negative regulation of cellular process
|
|
GS191792: GO:0070271 protein complex biogenesis
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS174644: HP:0000953 Hyperpigmentation of the skin
|
|
GS204317: GO:0009725 response to hormone stimulus
|
|
GS200986: GO:0032270 positive regulation of cellular protein metabolic process
|
|
GS209215: GO:0007166 cell surface receptor signaling pathway
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS175815: HP:0011025 Abnormality of cardiovascular system physiology
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS207065: GO:0051056 regulation of small GTPase mediated signal transduction
|
|
GS208230: GO:1901215 negative regulation of neuron death
|
|
GS188291: GO:0009967 positive regulation of signal transduction
|
|
GS125159: Rotenone interacting genes (MeSH:D012402) in CTD
|
|
GS176718: HP:0000078 Abnormality of the genital system
|
|
GS186442: GO:0071822 protein complex subunit organization
|
|
GS35239: Whole Brain Gene expression correlates of Background startle response in Males BXD
|
|
GS175893: HP:0000932 Abnormality of the posterior cranial fossa
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS191721: GO:0008284 positive regulation of cell proliferation
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS163852: MP:0001544 abnormal cardiovascular system physiology
|
|
GS197443: GO:0032549 ribonucleoside binding
|
|
GS125125: 2-Acetylaminofluorene interacting genes (MeSH:D015073) in CTD
|
|
GS174494: HP:0002564 Malformation of the heart and great vessels
|
|
GS172032: HP:0000366 Abnormality of the nose
|
|
GS125959: Cisplatin interacting genes (MeSH:D002945) in CTD
|
|
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
|
|
GS173372: HP:0011297 Abnormality of the digits
|
|
GS180134: GO:0046128 purine ribonucleoside metabolic process
|
|
GS136460: postnatal body weight growth 3 (Pbwg3, Published QTL Chr 7)
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS182313: GO:0044085 cellular component biogenesis
|
|
GS205165: GO:0010243 response to organic nitrogen
|
|
GS189350: GO:0042454 ribonucleoside catabolic process
|
|
GS192672: GO:0055086 nucleobase-containing small molecule metabolic process
|
|
GS165528: MP:0005379 endocrine/exocrine gland phenotype
|
|
GS190494: GO:0007254 JNK cascade
|
|
GS200490: GO:0061061 muscle structure development
|
|
GS206191: GO:0048584 positive regulation of response to stimulus
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS180122: GO:0009203 ribonucleoside triphosphate catabolic process
|
|
GS196595: GO:0006464 cellular protein modification process
|
|
GS166706: MP:0002166 altered tumor susceptibility
|
|
GS174412: HP:0007477 Abnormal dermatoglyphics
|
|
GS124165: Hydrogen Peroxide interacting genes (MeSH:D006861) in CTD
|
|
GS201737: GO:0007596 blood coagulation
|
|
GS210237: GO:0000902 cell morphogenesis
|
|
GS201132: GO:0010646 regulation of cell communication
|
|
GS126886: Malathion interacting genes (MeSH:D008294) in CTD
|
|
GS171893: HP:0011458 Abdominal symptom
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS195612: GO:0070304 positive regulation of stress-activated protein kinase signaling cascade
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS175674: HP:0007360 Aplasia/Hypoplasia of the cerebellum
|
|
GS180276: GO:0006195 purine nucleotide catabolic process
|
|
GS191106: GO:0044464 cell part
|
|
GS173290: HP:0011354 Generalized abnormality of skin
|
|
GS182095: GO:0080135 regulation of cellular response to stress
|
|
GS179517: GO:0012501 programmed cell death
|
|
GS177570: GO:0016043 cellular component organization
|
|
GS186227: GO:0090304 nucleic acid metabolic process
|
|
GS165716: MP:0010301 increased stomach tumor incidence
|
|
GS171654: HP:0003121 Limb joint contracture
|
|
GS203975: GO:0051932 synaptic transmission, GABAergic
|
|
GS196756: GO:0043523 regulation of neuron apoptotic process
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS172416: HP:0002242 Abnormality of the intestine
|
|
GS123494: docetaxel interacting genes (MeSH:C067311) in CTD
|
|
GS176241: HP:0010935 Abnormality of the upper urinary tract
|
|
GS204626: GO:0007173 epidermal growth factor receptor signaling pathway
|
|
GS198887: GO:0080135 regulation of cellular response to stress
|
|
GS177311: GO:1901361 organic cyclic compound catabolic process
|
|
GS171806: HP:0005656 Positional foot deformities
|
|
GS191738: GO:0022403 cell cycle phase
|
|
GS165516: MP:0010234 abnormal vibrissa follicle morphology
|
|
GS194628: GO:0008543 fibroblast growth factor receptor signaling pathway
|
|
GS121893: Vitamin E interacting genes (MeSH:D014810) in CTD
|
|
GS168579: MP:0003635 abnormal synaptic transmission
|
|
GS174187: HP:0001595 Abnormality of the hair
|
|
GS174292: HP:0011968 Feeding difficulties
|
|
GS167833: MP:0001784 abnormal fluid regulation
|
|
GS178840: GO:0010564 regulation of cell cycle process
|
|
GS171277: HP:0100547 Abnormality of the forebrain
|
|
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS171997: HP:0001762 Talipes equinovarus
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS180118: GO:0009207 purine ribonucleoside triphosphate catabolic process
|
|
GS183468: GO:0008022 protein C-terminus binding
|
|
GS178155: GO:0008219 cell death
|
|
GS203494: GO:0051704 multi-organism process
|
|
GS135396: body growth early QTL 6 (Bgeq6, Published QTL Chr 7)
|
|
GS173580: HP:0011994 Abnormality of the atrial septum
|
|
GS195085: GO:0007265 Ras protein signal transduction
|
|
GS173146: HP:0011282 Abnormality of the hindbrain
|
|
GS189374: GO:0042981 regulation of apoptotic process
|
|
GS172716: HP:0007206 Hemimegalencephaly
|
|
GS198622: GO:0038127 ERBB signaling pathway
|
|
GS177565: GO:0009166 nucleotide catabolic process
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS204315: GO:0007568 aging
|
|
GS177567: GO:0009164 nucleoside catabolic process
|
|
GS187708: GO:0009893 positive regulation of metabolic process
|
|
GS173137: HP:0011821 Abnormality of facial skeleton
|
|
GS179721: GO:0090398 cellular senescence
|
|
GS201131: GO:0010647 positive regulation of cell communication
|
|
GS175898: HP:0010535 Sleep apnea
|
|
GS171999: HP:0001760 Abnormality of the foot
|
|
GS181611: GO:0050673 epithelial cell proliferation
|
|
GS201800: GO:0032553 ribonucleotide binding
|
|
GS208388: GO:0048169 regulation of long-term neuronal synaptic plasticity
|
|
GS173763: HP:0001869 Deep plantar creases
|
|
GS197478: GO:0009628 response to abiotic stimulus
|
|
GS206696: GO:0044702 single organism reproductive process
|
|
GS170989: HP:0010766 Ectopic calcification
|
|
GS195086: GO:0007264 small GTPase mediated signal transduction
|
|
GS87378: Table S2: The data provided represent genes showing differential expression using ANOVA. (Whole Table) [DRG]
provisional
|
|
GS175604: HP:0005989 Redundant neck skin
|
|
GS136899: ventral midbrain iron content 3 (Vmbic3, Published QTL Chr 7)
|
|
GS188651: GO:0001883 purine nucleoside binding
|
|
GS176368: HP:0000260 Wide anterior fontanel
|
|
GS196284: GO:0012505 endomembrane system
|
|
GS172360: HP:0004323 Abnormality of body weight
|
|
GS180156: GO:0065008 regulation of biological quality
|
|
GS174920: HP:0000766 Abnormality of the sternum
|
|
GS177470: GO:0007346 regulation of mitotic cell cycle
|
|
GS184883: GO:0010942 positive regulation of cell death
|
|
GS127228: Tetranitromethane interacting genes (MeSH:D013774) in CTD
|
|
GS192256: GO:0007049 cell cycle
|
|
GS189484: GO:0023052 signaling
|
|
GS181712: GO:0050804 regulation of synaptic transmission
|
|
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS168826: MP:0005294 abnormal heart ventricle morphology
|
|
GS209928: GO:0006996 organelle organization
|
|
GS171720: HP:0005109 Abnormality of the Achilles tendon
|
|
GS127926: Hippocampal region - Allen Mouse Brain Atlas
|
|
GS202715: GO:0035637 multicellular organismal signaling
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS175880: HP:0007370 Aplasia/Hypoplasia of the corpus callosum
|
|
GS164669: MP:0010292 increased alimentary system tumor incidence
|
|
GS124516: Parathion interacting genes (MeSH:D010278) in CTD
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS125893: Tetradecanoylphorbol Acetate interacting genes (MeSH:D013755) in CTD
|
|
GS165074: MP:0010563 increased heart right ventricle size
|
|
GS206544: GO:2000112 regulation of cellular macromolecule biosynthetic process
|
|
GS176844: HP:0000429 Abnormality of the nasal alae
|
|
GS127932: Pallidum - Allen Mouse Brain Atlas
|
|
GS171253: HP:0002817 Abnormality of the upper limb
|
|
GS176672: HP:0000980 Pallor
|
|
GS173387: HP:0002757 Recurrent fractures
|
|
GS175588: HP:0001311 Neurophysiological abnormality
|
|
GS198684: GO:0048523 negative regulation of cellular process
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS176231: HP:0010938 Abnormality of the external nose
|
|
GS177597: GO:0043410 positive regulation of MAPK cascade
|
|
GS197669: GO:0051246 regulation of protein metabolic process
|
|
GS185254: GO:0051259 protein oligomerization
|
|
GS167797: MP:0008772 increased heart ventricle size
|
|
GS136924: VPA induced neural tube defect (Vpantd, Published QTL Chr 7)
|
|
GS189860: GO:0043167 ion binding
|
|
GS199501: GO:0051173 positive regulation of nitrogen compound metabolic process
|
|
GS170994: HP:0000085 Horseshoe kidney
|
|
GS174217: HP:0005105 Abnormal nasal morphology
|
|
GS176642: HP:0011355 Localized skin lesion
|
|
GS173744: HP:0000995 Pigmented nevi
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS163997: MP:0011655 abnormal systemic artery morphology
|
|
GS164560: MP:0004870 small premaxilla
|
|
GS206329: GO:0060255 regulation of macromolecule metabolic process
|
|
GS204054: GO:0044057 regulation of system process
|
|
GS173540: HP:0002115 Sparse or absent hair
|
|
GS124335: Copper interacting genes (MeSH:D003300) in CTD
|
|
GS187747: GO:0019226 transmission of nerve impulse
|
|
GS195199: GO:0005634 nucleus
|
|
GS193234: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS204804: GO:0071774 response to fibroblast growth factor stimulus
|
|
GS174764: HP:0007367 Atrophy/Degeneration affecting the central nervous system
|
|
GS167327: MP:0004468 small zygomatic bone
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS171752: HP:0001713 Abnormality of cardiac ventricle
|
|
GS172572: HP:0000347 Micrognathia
|
|
GS189240: GO:2001141 regulation of RNA biosynthetic process
|
|
GS170668: MP:0000272 abnormal aorta morphology
|
|
GS175083: HP:0008386 Aplasia/Hypoplasia of the nails
|
|
GS186178: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
|
|
GS182325: GO:0051716 cellular response to stimulus
|
|
GS121921: Sulfur Dioxide interacting genes (MeSH:D013458) in CTD
|
|
GS209951: GO:0042127 regulation of cell proliferation
|
|
GS34230: Cerebellum Gene expression correlates of Light-Dark Box Percentage of distance traveled in light compartment in Females BXD
|
|
GS173301: HP:0001800 Hypoplastic toenails
|
|
GS135817: ethanol induced thermoregulation 3 (Ethm3, Published QTL Chr 7)
|
|
GS182699: GO:0051174 regulation of phosphorus metabolic process
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS174186: HP:0001598 Concave nail
|
|
GS171587: HP:0001561 Polyhydramnios
|
|
GS186238: GO:0009144 purine nucleoside triphosphate metabolic process
|
|
GS178337: GO:0007264 small GTPase mediated signal transduction
|
|
GS164200: MP:0003667 hemangiosarcoma
|
|
GS125393: Superoxides interacting genes (MeSH:D013481) in CTD
|
|
GS207387: GO:0007254 JNK cascade
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS175886: HP:0007378 Neoplasm of the gastrointestinal tract
|
|
GS135577: cystic fibrosis lung disease 4 (Cfld4, Published QTL Chr 7)
|
|
GS172692: HP:0002659 Increased susceptibility to fractures
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS189896: GO:0009117 nucleotide metabolic process
|
|
GS185880: GO:0035637 multicellular organismal signaling
|
|
GS186994: GO:0051291 protein heterooligomerization
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS181666: GO:0019439 aromatic compound catabolic process
|
|
GS165970: MP:0002746 abnormal semilunar valve morphology
|
|
GS204610: GO:0019220 regulation of phosphate metabolic process
|
|
GS171658: HP:0000612 Iris coloboma
|
|
GS178333: GO:0007268 synaptic transmission
|
|
GS166930: MP:0002820 abnormal premaxilla morphology
|
|
GS193991: GO:0048731 system development
|
|
GS176029: HP:0009116 Aplasia/Hypoplasia involving bones of the skull
|
|
GS206405: GO:0010740 positive regulation of intracellular protein kinase cascade
|
|
GS175593: HP:0011015 Abnormality of blood glucose concentration
|
|
GS174899: HP:0100886 Abnormality of globe location
|
|
GS176695: HP:0009811 Abnormality of the elbow
|
|
GS181667: GO:0019438 aromatic compound biosynthetic process
|
|
GS168508: MP:0002051 skin papilloma
|
|
GS178170: GO:0006917 induction of apoptosis
|
|
GS188511: GO:0010468 regulation of gene expression
|
|
GS186067: GO:0050877 neurological system process
|
|
GS174868: HP:0002107 Pneumothorax
|
|
GS193018: GO:0003008 system process
|
|
GS199781: GO:0043067 regulation of programmed cell death
|
|
GS166163: MP:0010591 enlarged aortic valve
|
|
GS125548: Doxorubicin interacting genes (MeSH:D004317) in CTD
|
|
GS175459: HP:0009484 Deviation of the hand or of fingers of the hand
|
|
GS173839: HP:0002779 Tracheomalacia
|
|
GS205609: GO:0044431 Golgi apparatus part
|
|
GS184447: GO:0044424 intracellular part
|
|
GS189897: GO:0009116 nucleoside metabolic process
|
|
GS193236: GO:0031326 regulation of cellular biosynthetic process
|
|
GS210560: GO:0071310 cellular response to organic substance
|
|
GS171394: HP:0000174 Abnormality of the palate
|
|
GS179864: GO:0070997 neuron death
|
|
GS193489: GO:0072521 purine-containing compound metabolic process
|
|
GS206810: GO:0071156 regulation of cell cycle arrest
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS175703: HP:0003003 Colon cancer
|
|
GS206356: GO:0023051 regulation of signaling
|
|
GS163080: MP:0010273 increased classified tumor incidence
|
|
GS191021: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS197555: GO:0007050 cell cycle arrest
|
|
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS125545: Iron interacting genes (MeSH:D007501) in CTD
|
|
GS203335: GO:0048513 organ development
|
|
GS204316: GO:0007569 cell aging
|
|
GS174809: HP:0001634 Mitral valve prolapse
|
|
GS175191: HP:0002060 Abnormality of the cerebrum
|
|
GS190410: GO:0080134 regulation of response to stress
|
|
GS195036: GO:0031090 organelle membrane
|
|
GS124810: Urethane interacting genes (MeSH:D014520) in CTD
|
|
GS123911: Ozone interacting genes (MeSH:D010126) in CTD
|
|
GS171448: HP:0000606 Abnormality of the periorbital region
|
|
GS182234: GO:0036211 protein modification process
|
|
GS164534: MP:0002019 abnormal tumor incidence
|
|
GS122988: Chlorodiphenyl (54% Chlorine) interacting genes (MeSH:D020111) in CTD
|
|
GS210212: GO:0005575 cellular_component
|
|
GS174081: HP:0004322 Short stature
|
|
GS195291: GO:0006355 regulation of transcription, DNA-dependent
|
|
GS177334: GO:0016192 vesicle-mediated transport
|
|
GS205369: GO:0010468 regulation of gene expression
|
|
GS173020: HP:0000818 Abnormality of the endocrine system
|
|
GS188762: GO:0009889 regulation of biosynthetic process
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS182979: GO:0043065 positive regulation of apoptotic process
|
|
GS135999: hepatic lipase activity in BSB 1 (Hlbsb1, Published QTL Chr 7)
|
|
GS175885: HP:0007379 Neoplasm of the genitourinary tract
|
|
GS175583: HP:0010438 Abnormality of the ventricular septum
|
|
GS164826: MP:0010577 abnormal heart right ventricle size
|
|
GS204964: GO:0050900 leukocyte migration
|
|
GS199880: GO:0033674 positive regulation of kinase activity
|
|
GS169708: MP:0005416 abnormal circulating protein level
|
|
GS179580: GO:0036094 small molecule binding
|
|
GS136272: multigenic obesity QTL 1 (Mobq1, Published QTL Chr 7)
|
|
GS194038: GO:1901362 organic cyclic compound biosynthetic process
|
|
GS194703: GO:0051726 regulation of cell cycle
|
|
GS205123: GO:0030029 actin filament-based process
|
|
GS175995: HP:0000465 Webbed neck
|
|
GS170905: HP:0004400 Abnormality of the pylorus
|
|
GS196993: GO:0008542 visual learning
|
|
GS172033: HP:0000369 Low-set ears
|
|
GS172756: HP:0001357 Plagiocephaly
|
|
GS183803: GO:0044267 cellular protein metabolic process
|
|
GS168505: MP:0002052 decreased tumor incidence
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS123916: Aflatoxin B1 interacting genes (MeSH:D016604) in CTD
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS167735: MP:0002817 abnormal tooth mineralization
|
|
GS174211: HP:0009465 Ulnar deviation of finger
|
|
GS168149: MP:0005508 abnormal skeleton morphology
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS202000: GO:0000082 G1/S transition of mitotic cell cycle
|
|
GS164263: MP:0002083 premature death
|
|
GS165616: MP:0002127 abnormal cardiovascular system morphology
|
|
GS201695: GO:0010942 positive regulation of cell death
|
|
GS210180: GO:0031326 regulation of cellular biosynthetic process
|
|
GS208658: GO:0008285 negative regulation of cell proliferation
|
|
GS209073: GO:0045860 positive regulation of protein kinase activity
|
|
GS135492: behavioral response to methamphetamines 6 (Brmth6, Published QTL Chr 7)
|
|
GS182834: GO:0005623 cell
|
|
GS122047: Ethylnitrosourea interacting genes (MeSH:D005038) in CTD
|
|
GS205622: GO:0009889 regulation of biosynthetic process
|
|
GS205418: GO:0042327 positive regulation of phosphorylation
|
|
GS205511: GO:0001882 nucleoside binding
|
|
GS170889: HP:0006482 Abnormality of dental morphology
|
|
GS200264: GO:0008022 protein C-terminus binding
|
|
GS171919: HP:0002198 Dilated fourth ventricle
|
|
GS189460: GO:0060255 regulation of macromolecule metabolic process
|
|
GS172028: HP:0000363 Abnormality of earlobe
|